Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.65 |
| ▸ | HPGD | P15428 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | XBP1 | P17861 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | MYC | P01106 | 1/20 | 0.40 |
| ▸ | WDR5 | P61964 | 1/20 | 0.40 |
| ▸ | RARA | P10276 | 1/20 | 0.40 |
| ▸ | RARB | P10826 | 1/20 | 0.40 |
| ▸ | RARG | P13631 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2090659 | 0.83 | ALDH1A1 (0.61) | ALDH1A1HPGDSMN1; SMN2KDM4ELMNA | |
| SCHEMBL8188473 | 0.83 | ALDH1A1 (0.61) | ALDH1A1HPGDSMN1; SMN2NPSR1MYC | |
| SCHEMBL2093741 | 0.83 | ALDH1A1 (0.59) | ALDH1A1HPGDSMN1; SMN2MAPTRARA | |
| Ammonia Solution, Strong SCHEMBL8553360 | 0.82 | ALDH1A1 (0.59) | ALDH1A1HPGDSMN1; SMN2KDM4ELMNA | |
| SCHEMBL8472083 | 0.81 | ALDH1A1 (0.58) | ALDH1A1HPGDSMN1; SMN2KDM4ELMNA | |
| SCHEMBL8202114 | 0.80 | ALDH1A1 (0.96) | ALDH1A1HPGDSMN1; SMN2KDM4ELMNA | |
| SCHEMBL2303869 | 0.79 | SMN1; SMN2 (0.70) | ALDH1A1HPGDSMN1; SMN2KDM4ELMNA | |
| SCHEMBL28672395 | 0.79 | SMN1; SMN2 (0.46) | ALDH1A1HPGDSMN1; SMN2KDM4ELMNA | |
| SCHEMBL8188518 | 0.79 | ALDH1A1 (0.56) | ALDH1A1HPGDSMN1; SMN2KDM4ELMNA | |
| SCHEMBL15423314 | 0.79 | ALDH1A1 (0.56) | ALDH1A1HPGDSMN1; SMN2MAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8834619-B2 | Ink composition, ink for inkjet recording and inkjet recording method | FUJIFILM CORPORATION (JP) | 2014-09-16 | — | — | US | disclosed |
| US-8834619-B2 | Ink composition, ink for inkjet recording and inkjet recording method | FUJIFILM CORPORATION (JP) | 2014-09-16 | — | — | US | disclosed |
| EP-2687565-A1 | INK COMPOSITION, INKJET PRINTING INK, AND INKJET PRINTING METHOD | FUJIFILM Corporation (JP) | 2014-01-22 | — | — | EP | disclosed |
| US-20140013997-A1 | INK COMPOSITION, INK FOR INKJET RECORDING AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2014-01-16 | — | — | US | disclosed |
| US-20140013997-A1 | INK COMPOSITION, INK FOR INKJET RECORDING AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2014-01-16 | — | — | US | disclosed |
| US-20110105491-A1 | THIAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD. (CH) | 2011-05-05 | — | — | US | disclosed |
| US-20110105491-A1 | THIAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD. (CH) | 2011-05-05 | — | — | US | disclosed |
| US-7758683-B2 | Ink composition, ink set and recording method | FUJIFILM CORPORATION (JP) | 2010-07-20 | — | — | US | disclosed |
| US-7758683-B2 | Ink composition, ink set and recording method | FUJIFILM CORPORATION (JP) | 2010-07-20 | — | — | US | disclosed |
| US-7704311-B2 | Ink composition, manufacturing method of ink, ink set, and recording method | FUJIFILM CORPORATION (JP) | 2010-04-27 | — | — | US | disclosed |
| US-7704311-B2 | Ink composition, manufacturing method of ink, ink set, and recording method | FUJIFILM CORPORATION (JP) | 2010-04-27 | — | — | US | disclosed |
| WO-2010004507-A1 | THIAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2010-01-14 | — | — | WO | disclosed |
| US-7465344-B2 | Ink for ink jet recording comprising print density improver, print density improver and method for improving print density | FUJIFILM CORPORATION (JP) | 2008-12-16 | — | — | US | disclosed |
| US-7465344-B2 | Ink for ink jet recording comprising print density improver, print density improver and method for improving print density | FUJIFILM CORPORATION (JP) | 2008-12-16 | — | — | US | disclosed |
| US-7431760-B2 | Ink and ink-jet recording ink | FUJIFILM CORPORATION (JP) | 2008-10-07 | — | — | US | disclosed |
| US-7431760-B2 | Ink and ink-jet recording ink | FUJIFILM CORPORATION (JP) | 2008-10-07 | — | — | US | disclosed |
| WO-2008087611-A2 | PYRROLIDINE- AND PIPERIDINE- BIS-AMIDE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2008-07-24 | — | — | WO | disclosed |
| US-20070109376-A1 | Ink composition, ink set and recording method | FUJIFILM CORPORATION | 2007-05-17 | — | — | US | disclosed |
| US-20070109376-A1 | Ink composition, ink set and recording method | FUJIFILM CORPORATION | 2007-05-17 | — | — | US | disclosed |
| WO-2007046553-A1 | INK COMPOSITION, MANUFACTURING METHOD OF INK, INK SET, AND RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2007-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105491-A1 | THIAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | HCRTR2, HCRTR1, OXTR | ALDH1A1 690/4885HPGD 2597/4885SMN1; SMN2 3479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.